Related Experiment Videos
[125I-n-iodophenamine as a prototype compound for the study of microsomal oxidation]
Abstract:
Dynamics of distribution and excretion with urine of 125I-p-iodophenamine were studied impairment of rat liver tissue microsomal oxidation by means of CC14 treatment. This poison inhibited distinctly metabolism and excretion of the labelled compound in rats but not in rabbits, which was due to difference in the mechanisms of the compound biotransformation. The requirements for compounds suitable for studies of microsomal oxidation by means of excretory test were not met by 125I-p-iodophenamine.
Insights
Carbon tetrachloride (CCl4) impairs liver microsomal oxidation, affecting the metabolism and excretion of 125I-p-iodophenamine in rats. This study highlights species-specific differences in biotransformation, indicating 125I-p-iodophenamine is unsuitable for excretory tests of microsomal oxidation.
Area of Science:
- Pharmacology and Toxicology
- Biochemistry and Molecular Biology
- Drug Metabolism and Pharmacokinetics
Context:
- Microsomal oxidation is a key hepatic detoxification pathway.
- Carbon tetrachloride (CCl4) is a known hepatotoxin that induces oxidative stress and impairs liver function.
- Understanding xenobiotic metabolism is crucial for assessing drug safety and efficacy.
Purpose:
- To investigate the impact of CCl4-induced liver microsomal impairment on the distribution and urinary excretion of 125I-p-iodophenamine.
- To compare the biotransformation and excretion patterns of 125I-p-iodophenamine in rats and rabbits following CCl4 treatment.
- To evaluate the suitability of 125I-p-iodophenamine as a probe for studying microsomal oxidation via excretory tests.
Summary:
- CCl4 treatment significantly inhibited the metabolism and urinary excretion of 125I-p-iodophenamine in rats.
- Rabbits showed no such inhibition, suggesting species-specific differences in the biotransformation pathways of 125I-p-iodophenamine.
- The findings indicate that 125I-p-iodophenamine is not an appropriate compound for assessing microsomal oxidation using excretory tests due to variable metabolic handling.
Impact:
- Provides insights into the differential effects of hepatotoxins on xenobiotic metabolism across species.
- Clarifies the limitations of using 125I-p-iodophenamine for evaluating liver microsomal function in toxicological studies.
- Underscores the importance of considering species-specific metabolic differences in drug development and toxicological risk assessment.